Aralez Pharmaceuticals Inc. (fka ARLZQ)

[jrf30]

Question doc.

" REVENUES will increase 50% from 100 million dollars in 2017 to 150 million dollars in 2018! And the company will go from EBDITA neutral in 2017 to about 50 MILLION DOLLARS in 2018! "

SO revenues of $100 million got them break even. But if revenues go up to 4150 million, they should earn $50 million EBDITA? How is that? the first $100 million cost about $100 million, and yet the next $50 million in revenues will be done with ZERO expenses against it, leaving it all as profit?

Doesn't seem feasible. What am I missing here? Do you think they will net $50 million in 2018? Curious. Let me know your thoughts. Doing my DD now, and input is always still a good way to hear what others think as well. thanks.